These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Iron chelators for acute stroke. Van der Loo LE; Aquarius R; Teernstra O; Klijn K; Menovsky T; van Dijk JMC; Bartels R; Boogaarts HD Cochrane Database Syst Rev; 2020 Nov; 11(11):CD009280. PubMed ID: 33236783 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of prophylactic levetiracetam for prevention of epileptic seizures in the acute phase of intracerebral haemorrhage (PEACH): a randomised, double-blind, placebo-controlled, phase 3 trial. Peter-Derex L; Philippeau F; Garnier P; André-Obadia N; Boulogne S; Catenoix H; Convers P; Mazzola L; Gouttard M; Esteban M; Fontaine J; Mechtouff L; Ong E; Cho TH; Nighoghossian N; Perreton N; Termoz A; Haesebaert J; Schott AM; Rabilloud M; Pivot C; Dhelens C; Filip A; Berthezène Y; Rheims S; Boutitie F; Derex L Lancet Neurol; 2022 Sep; 21(9):781-791. PubMed ID: 35963261 [TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of GABA Chabriat H; Bassetti CL; Marx U; Audoli-Inthavong ML; Sors A; Lambert E; Wattez M; Hermann DM; Lancet Neurol; 2020 Mar; 19(3):226-233. PubMed ID: 32085836 [TBL] [Abstract][Full Text] [Related]
12. Effect of Deferoxamine on Trajectory of Recovery After Intracerebral Hemorrhage: A Post Hoc Analysis of the i-DEF Trial. Foster L; Robinson L; Yeatts SD; Conwit RA; Shehadah A; Lioutas V; Selim M; Stroke; 2022 Jul; 53(7):2204-2210. PubMed ID: 35306827 [TBL] [Abstract][Full Text] [Related]
13. The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial. Ma L; Hu X; Song L; Chen X; Ouyang M; Billot L; Li Q; Malavera A; Li X; Muñoz-Venturelli P; de Silva A; Thang NH; Wahab KW; Pandian JD; Wasay M; Pontes-Neto OM; Abanto C; Arauz A; Shi H; Tang G; Zhu S; She X; Liu L; Sakamoto Y; You S; Han Q; Crutzen B; Cheung E; Li Y; Wang X; Chen C; Liu F; Zhao Y; Li H; Liu Y; Jiang Y; Chen L; Wu B; Liu M; Xu J; You C; Anderson CS; Lancet; 2023 Jul; 402(10395):27-40. PubMed ID: 37245517 [TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial. Albers GW; von Kummer R; Truelsen T; Jensen JK; Ravn GM; Grønning BA; Chabriat H; Chang KC; Davalos AE; Ford GA; Grotta J; Kaste M; Schwamm LH; Shuaib A; Lancet Neurol; 2015 Jun; 14(6):575-84. PubMed ID: 25937443 [TBL] [Abstract][Full Text] [Related]
15. Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial. Hanley DF; Lane K; McBee N; Ziai W; Tuhrim S; Lees KR; Dawson J; Gandhi D; Ullman N; Mould WA; Mayo SW; Mendelow AD; Gregson B; Butcher K; Vespa P; Wright DW; Kase CS; Carhuapoma JR; Keyl PM; Diener-West M; Muschelli J; Betz JF; Thompson CB; Sugar EA; Yenokyan G; Janis S; John S; Harnof S; Lopez GA; Aldrich EF; Harrigan MR; Ansari S; Jallo J; Caron JL; LeDoux D; Adeoye O; Zuccarello M; Adams HP; Rosenblum M; Thompson RE; Awad IA; Lancet; 2017 Feb; 389(10069):603-611. PubMed ID: 28081952 [TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study. Klopstock T; Tricta F; Neumayr L; Karin I; Zorzi G; Fradette C; Kmieć T; Büchner B; Steele HE; Horvath R; Chinnery PF; Basu A; Küpper C; Neuhofer C; Kálmán B; Dušek P; Yapici Z; Wilson I; Zhao F; Zibordi F; Nardocci N; Aguilar C; Hayflick SJ; Spino M; Blamire AM; Hogarth P; Vichinsky E Lancet Neurol; 2019 Jul; 18(7):631-642. PubMed ID: 31202468 [TBL] [Abstract][Full Text] [Related]
17. High-dose albumin treatment for acute ischaemic stroke (ALIAS) Part 2: a randomised, double-blind, phase 3, placebo-controlled trial. Ginsberg MD; Palesch YY; Hill MD; Martin RH; Moy CS; Barsan WG; Waldman BD; Tamariz D; Ryckborst KJ; Lancet Neurol; 2013 Nov; 12(11):1049-58. PubMed ID: 24076337 [TBL] [Abstract][Full Text] [Related]
18. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial. Baharoglu MI; Cordonnier C; Al-Shahi Salman R; de Gans K; Koopman MM; Brand A; Majoie CB; Beenen LF; Marquering HA; Vermeulen M; Nederkoorn PJ; de Haan RJ; Roos YB; Lancet; 2016 Jun; 387(10038):2605-2613. PubMed ID: 27178479 [TBL] [Abstract][Full Text] [Related]
19. Prehospital transdermal glyceryl trinitrate in patients with presumed acute stroke (MR ASAP): an ambulance-based, multicentre, randomised, open-label, blinded endpoint, phase 3 trial. van den Berg SA; Uniken Venema SM; Reinink H; Hofmeijer J; Schonewille WJ; Miedema I; Fransen PSS; O Pruissen DM; Raaijmakers TWM; van Dijk GW; de Leeuw FE; van Vliet JA; Kwa VIH; Kerkhoff H; van 't Net A; Boomars R; Siegers A; Lok T; Caminada K; Esteve Cuevas LM; Visser MC; Zwetsloot CP; Boomsma JMF; Schipper MH; van Eijkelenburg RPJ; Berkhemer OA; Nieboer D; Lingsma HF; Emmer BJ; van Oostenbrugge RJ; van der Lugt A; Roos YBWEM; Majoie CBLM; Dippel DWJ; Nederkoorn PJ; van der Worp HB; Lancet Neurol; 2022 Nov; 21(11):971-981. PubMed ID: 36058230 [TBL] [Abstract][Full Text] [Related]
20. Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial. NINDS Exploratory Trials in Parkinson Disease (NET-PD) FS-ZONE Investigators Lancet Neurol; 2015 Aug; 14(8):795-803. PubMed ID: 26116315 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]